Pedro Piedra MD
Professor, Virology & Microbiology, Baylor College of Medicine
Join to view full profile
One Baylor PlazaMS BCM 280Houston, TX 77030
Phone+1 713-798-5240
Dr. Piedra is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloFellowship, Pediatric Infectious Diseases, 1984 - 1987
Medical University of South CarolinaResidency, Pediatrics, 1981 - 1984
University of South Florida College of MedicineClass of 1981
Certifications & Licensure
TX State Medical License 1988 - 2027
SC State Medical License 1982 - 1984
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- Respiratory Viral Detection and Invasive Bacterial Infections in Infants ≤90 Days.Erin G Nicholson, Tess Stopczynski, Leila C Sahni, Vasanthi Avadhanula, Justin Z Amarin
The Pediatric Infectious Disease Journal. 2026-08-10 - 7 citationsMaternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.Christina A Rostad, C Mary Healy, Jennifer L Nayak, Lalitha Parameswaran, C Buddy Creech
Pediatrics. 2026-06-01 - colonization modulates human nasal epithelial responses to respiratory syncytial virus infection.Leah A Kafer, Isabel F Escapa, Andrea I Boyd, Alejandra Rivera Tostado, Amal Kambal
Biorxiv. 2026-02-05
Other
- Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-03-13 - Respiratory Syncytial Virus Fusion Nanoparticle Vaccine Immune Responses Target Multiple Neutralizing Epitopes That Contribute to Protection Against Wild-Type and Pali...Pedro Piedra, MD, ScienceDirect
https://www.doximity.com/articles/ec82b951-b191-4406-8038-7129da66ac6c
UpToDate, Wolters Kluwer Health - 2013-01-09
Press Mentions
Flu Season Approaches: Key Updates on Vaccines and SymptomsSeptember 17th, 2025
Flu Season: Vaccines, Symptoms and MoreSeptember 17th, 2025
It’s a First: Implementing Safe and Effective RSV Prevention Treatments Significantly Reduces Hospitalizations in InfantsJune 10th, 2025
Grant Support
- Human Biomimetics for Mucosal InfectionsBAYLOR COLLEGE OF MEDICINE2015–2026
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: